William Chalmers

Aug 7, 2023 | lexblog.com | William Chalmers |Christopher A. Guerreiro |Anna Wilkinson |Kristin Wall

On August 7, 2023, the Canadian Intellectual Property Office (CIPO) launched a consultation on proposed features of regulations on patent term adjustment (PTA) in Canada (the Consultation). The PTA system is intended to compensate patentees for “unreasonable delays” by CIPO in issuing a patent. The Consultation seeks feedback on proposals that would impact the length of the PTA term, in order to inform the development of draft amendments to the Patent Rules.

Jan 25, 2023 | lexblog.com | William Chalmers |Christopher A. Guerreiro |Paul Jorgensen |Kristin Wall

Does 2022 already seem like a blur? The Pharma in Brief team is here for you with a summary of some of 2022’s most significant legal and regulatory developments in the Canadian pharmaceutical space. We also flag what to watch out for in 2023.  The most significant legislative changes concerned the Patent Act and accompanying rules/regulations.